In March 2025, the Company raised $ 215,789 in proceeds in the IPO after deducting underwriting discounts and commissions and before deducting IPO offering costs of
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
The Common Shares were sold pursuant to an Underwriting Agreement, dated December 2, 2025, between the Company and BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman S…
Kestra Medical Technologies, Ltd. Customers
No clients on recordNo downstream customers found in our database for Kestra Medical Technologies, Ltd..
Kestra Medical Technologies, Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
KMTS-DEBT-10538
Warrants outstanding: 2648000
90%
xbrl warrant detail from xbrl 2025-04-30.
KMTS-DEBT
Debt stack $46.5M
90%
Market cache reports total debt of $46.5M.
Kestra Medical Technologies, Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Kestra Medical Technologies, Ltd..
Kestra Medical Technologies, Ltd. Ownership
Holder
Name
Confidence
Evidence
KMTS-OWNER-BAIN-CAPITAL-INVESTORS-LLC
Bain Capital Investors LLC
90%
13F overlay lists Bain Capital Investors LLC as top holder; 104 tracked holders.
Kestra Medical Technologies, Ltd. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
Kestra Medical Technologies, Ltd. Supply Chain Intel
